Dr. Nelya Melnitchouk

Dr. Melnitchouk is an associate surgeon at Brigham and Women’s Hospital (BWH) and Brigham and Women’s Faulkner Hospital (BWFH) and assistant professor of surgery at Harvard Medical School.Dr. Melnitchouk received her medical degree from Albert Einstein College of Medicine. She completed her general surgery residency at Brigham and Women’s Hospital/Harvard Medical School. As a resident, she received the Rudolph Vollman Award for excellence in teaching and contributed to multiple HMS research projects on colon and rectal surgery procedures. She completed a colorectal surgery fellowship at the combined Memorial Sloan Kettering Cancer Center and New York Hospital/Weill Cornell Medical Center Colorectal Surgery Program. She is board-certified in general surgery and Colon and Rectal Surgery.She founded and leads a Program in Peritoneal Surface Malignancy, focusing on treating patients with appendiceal cancer, colorectal cancer, and peritoneal mesothelioma through a multidisciplinary personalized approach emphasizing shared decision-making. Dr. Melnitchouk is a highly experienced surgeon offering cytoreduction and heated intraperitoneal chemotherapy (HIPEC) to patients with peritoneal surface malignancy and leads a research program with an emphasis on early recovery and clinical trials. Her other research interests are global health, colorectal cancer screening and surgery for colorectal cancer in low-to-middle-income countries, quality, and safety. Her clinical interests include minimally invasive surgery (laparoscopic, robotic, and combined endoscopic, laparoscopic surgery), sphincter preserving/saving surgery in rectal cancer, colon and rectal cancer, and inflammatory bowel disorders.

Dr. Melnitchouk is rated as an Experienced provider by MediFind in the treatment of Anorectal Abscess. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, Appendectomy, and Ureteroscopy.

Her clinical research consists of co-authoring 109 peer reviewed articles. MediFind looks at clinical research from the past 15 years.